These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38571687)

  • 1. Radiomics Analysis of Contrast-Enhanced Breast MRI for Optimized Modelling of Virtual Prognostic Biomarkers in Breast Cancer.
    Polat DS; Xi Y; Hulsey K; Lewis M; Dogan BE
    Eur J Breast Health; 2024 Apr; 20(2):122-128. PubMed ID: 38571687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer.
    Huang Y; Wei L; Hu Y; Shao N; Lin Y; He S; Shi H; Zhang X; Lin Y
    Front Oncol; 2021; 11():706733. PubMed ID: 34490107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
    Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive ductal breast cancer molecular subtype prediction by MRI radiomic and clinical features based on machine learning.
    Sheng W; Xia S; Wang Y; Yan L; Ke S; Mellisa E; Gong F; Zheng Y; Tang T
    Front Oncol; 2022; 12():964605. PubMed ID: 36172153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
    Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
    Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound deep learning radiomics and clinical machine learning models to predict low nuclear grade, ER, PR, and HER2 receptor status in pure ductal carcinoma
    Zhu M; Kuang Y; Jiang Z; Liu J; Zhang H; Zhao H; Luo H; Chen Y; Peng Y
    Gland Surg; 2024 Apr; 13(4):512-527. PubMed ID: 38720675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer Surrogate Subtype Classification Using Pretreatment Multi-Phase Dynamic Contrast-Enhanced Magnetic Resonance Imaging Radiomics: A Retrospective Single-Center Study.
    Kovačević L; Štajduhar A; Stemberger K; Korša L; Marušić Z; Prutki M
    J Pers Med; 2023 Jul; 13(7):. PubMed ID: 37511763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of MRI Radiomics Models in Evaluating the Low HER2 Expression in Breast Cancer.
    Li H; Hou Y; Xue LY; Fan WL; Gao BL; Yin XP
    Curr Med Imaging; 2024; 20():e15734056234429. PubMed ID: 38726785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Texture Analysis Using Semiquantitative Kinetic Parameter Maps from DCE-MRI: Preoperative Prediction of HER2 Status in Breast Cancer.
    Song L; Li C; Yin J
    Front Oncol; 2021; 11():675160. PubMed ID: 34168994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study.
    Zhang S; Wang X; Yang Z; Zhu Y; Zhao N; Li Y; He J; Sun H; Xie Z
    Front Oncol; 2022; 12():905551. PubMed ID: 35814460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced magnetic resonance imaging radiomics analysis based on intratumoral subregions for predicting luminal and nonluminal breast cancer.
    Feng S; Yin J
    Quant Imaging Med Surg; 2023 Oct; 13(10):6735-6749. PubMed ID: 37869317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
    Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
    J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
    Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
    Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer.
    Demircioglu A; Grueneisen J; Ingenwerth M; Hoffmann O; Pinker-Domenig K; Morris E; Haubold J; Forsting M; Nensa F; Umutlu L
    PLoS One; 2020; 15(6):e0234871. PubMed ID: 32589681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
    Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
    Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-Enhanced Mammography Radiomics Analysis for Preoperative Prediction of Breast Cancer Molecular Subtypes.
    Zhu S; Wang S; Guo S; Wu R; Zhang J; Kong M; Pan L; Gu Y; Yu S
    Acad Radiol; 2024 Jun; 31(6):2228-2238. PubMed ID: 38142176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
    Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
    Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction for pathological and immunohistochemical characteristics of triple-negative invasive breast carcinomas: the performance comparison between quantitative and qualitative sonographic feature analysis.
    Li JW; Cao YC; Zhao ZJ; Shi ZT; Duan XQ; Chang C; Chen JG
    Eur Radiol; 2022 Mar; 32(3):1590-1600. PubMed ID: 34519862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set.
    Li H; Zhu Y; Burnside ES; Huang E; Drukker K; Hoadley KA; Fan C; Conzen SD; Zuley M; Net JM; Sutton E; Whitman GJ; Morris E; Perou CM; Ji Y; Giger ML
    NPJ Breast Cancer; 2016; 2():16012-. PubMed ID: 27853751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.